Clinical Trials Logo

Nervous System Diseases clinical trials

View clinical trials related to Nervous System Diseases.

Filter by:

NCT ID: NCT03753841 Completed - Dysphagia Clinical Trials

FEES to Determine Neurological Intensive Care Patients' Oral Diet

Start date: January 14, 2014
Phase: N/A
Study type: Interventional

Dysphagia is associated with high rates of mortality and morbidity. Adjusting the oral diet of ICU-patients based on flexible endoscopic evaluation of swallowing (FEES) findings might reduce pneumonia rate, mortality and need for intubation/tracheotomy.

NCT ID: NCT03750188 Completed - Clinical trials for Central Nervous System Diseases

Evaluation of Safety and Efficacy of ProHance in Pediatric Patients <2yrs

Start date: November 1, 2018
Phase:
Study type: Observational

Safety and Efficacy Study in pediatric subjects <2 years of age who have undergone Brain or Spine MRI pre and post 0.1 mmol/kg ProHance administration. Imaging conditions will represent those in routine clinical practice. Retrospective enrolment with a prospective blinded read.

NCT ID: NCT03737331 Terminated - Clinical trials for Gait Disorders, Neurologic

Variable Visual Stimulus as a Novel Approach for Gait Rehabilitation

VISNA
Start date: November 9, 2018
Phase: N/A
Study type: Interventional

Deterioration in walking performance as a result of disease or simply as a result of aging is a serious threat to independence in older adults. In this project, the investigators propose an innovative visual stimulus, based on advanced mathematical and biological theories, with which older adults can walk in time to improve their walking. The investigators' goal is to apply this simple, cost-effective, and novel gait rehabilitation therapy across all populations who have difficulties walking, e.g. stroke patients, fallers or those who undergo joint replacement.

NCT ID: NCT03735654 Not yet recruiting - Multiple Sclerosis Clinical Trials

Multi-joint Muscle Fatigability and Gait Performance in People With Multiple Sclerosis

MS_Gait
Start date: November 15, 2018
Phase:
Study type: Observational

The purpose of this study is to compare walking to leg strength and endurance in people with multiple sclerosis (PwMS). Using these findings, we hope to be better understand what causes PwMS to have problems walking.

NCT ID: NCT03731078 Terminated - Clinical trials for Functional Neurological Disorder

Pilot Study of Cognitive Behavioral Therapy-Informed Physical Therapy Intervention in Functional Neurological Disorders

Start date: March 8, 2019
Phase:
Study type: Observational

Functional Neurological Disorder (FND/ Conversion Disorder) is a highly prevalent and disabling neuropsychiatric condition. Motor FND symptoms include Functional Movement Disorders (FMD) and Functional Weakness and Psychogenic Nonepileptic Seizures (PNES).Though patients with FND present with a wide variety of symptoms, FMD, PNES, and functional weakness may be viewed as overlapping conditions lying along a phenotypic spectrum for a single disorder. Patients with FND frequently present with psychiatric symptoms, including depression, anxiety, Borderline Personality Disorder, and Post-Traumatic Stress Disorder, alongside their physical symptoms. To treat these symptoms, patients with FND are frequently enrolled in physical therapy and cognitive behavioral therapy, which are considered usual care for FND at our center. Developing a further understanding of treatment outcome, including biomarkers of clinical improvement and psychometric factors associated with treatment response, could inform future interventions and better tailor treatments to patients with specific FND symptom profiles. We hypothesize that treatment response will be associated with structural and functional alterations in salience network regions and that more adaptive neuropsychiatric profiles at baseline will predict a positive treatment outcome.

NCT ID: NCT03727529 Recruiting - Parkinson Disease Clinical Trials

Immersive Virtual Reality to Improve Gait in Parkinson's Disease

NMSK-LH02
Start date: January 30, 2019
Phase: N/A
Study type: Interventional

Parkinson's Disease (PD) patients suffer from gait impairments responsible for falls and bad quality of life: reduced speed and stride length, randomness in stride duration variability (reduced Long-Range Autocorrelations (LRA)). On the other hand, treadmill walking has shown long-term effectiveness on PD patients' gait and quality of life. The purpose of this single blinded randomized controlled trial is to study the effect of a combination of immersive virtual reality and treadmill walking on LRA.

NCT ID: NCT03709407 Completed - Blood Pressure Clinical Trials

"Effects of Manual Lymphatic Drainage in the Neck in Healthy Subjects. Experimental Randomized Crossover Study"

Start date: June 1, 2018
Phase: N/A
Study type: Interventional

Drainage manoeuvres described in different Manual Lymphatic Drainage methods, suggest modificactions in vital signs, by changes at nervous system, that would involve modifications to heart rate, breathing rate, blood pressure, cardiac vascular level (arteries and lymphatics). In addition this hypothetical relaxing effect could be beneficial for other types of pathologies associated with the presence of stress, cardiac problems, respiratory pathology, muscle tension, muscle trigger points, etc. With this study investigators compare different manoeuvres in the neck area to observe the results in the participants regarding the basal state.

NCT ID: NCT03704168 Withdrawn - Neurologic Disorder Clinical Trials

Safety and Efficacy of Cryoablation in Management of Sialorrhea in Patients With Neurological Disorders

SECAMS
Start date: May 1, 2019
Phase: N/A
Study type: Interventional

To evaluate safety of cryoablation of submandibular glands in management of sialorrhea in neurologically impaired populations. Secondary Objective: To evaluate efficacy of cryoablation of submandibular glands in management of sialorrhea in neurologically impaired populations. Duration: Estimation for Recruitment: 12 months Estimation for Procedure/Trial: 1 visit with an overnight observation Estimation for Subject Follow Up: 7 days, 14 days, 28 days, 90 days, and 180 days, post ablation, with ultrasound of the bilateral submandibular glands at 28 days and 180 days post ablation Total Expected Duration for Clinical Trial: 2 years

NCT ID: NCT03699514 Recruiting - Healthy Clinical Trials

Post Hoc Analysis and Clinical Data Collection for Subjects Tested With Brain Network Activation (BNA™) Technology

Start date: May 1, 2018
Phase:
Study type: Observational

The study is designed to collect data that will aid in future scientific and engineering exploration of correlations between clinical assessments and BNA scores. The results are primarily intended for scientific inquiry and engineering development purposes, and may be used in future regulatory submissions.

NCT ID: NCT03678194 Recruiting - Depression Clinical Trials

Treating Depression on a Day-to-day Basis: Development of a Tool for Physicians Based on a Smartphone Application

SMART
Start date: October 14, 2020
Phase: N/A
Study type: Interventional

Testing and validating an e-health (smartphone application) approach to better understand the determinants of day-to-day symptomatology in depression, medication adherence, and treatment efficacy in the goal of maximizing patient care.